Status:

UNKNOWN

the Efficacy of Fetal Arterial and Venous Doppler Indices in Predicting Perinatal Outcome

Lead Sponsor:

Cairo University

Conditions:

Gestational Diabetes

Pre-Gestational Diabetes

Eligibility:

FEMALE

18-35 years

Brief Summary

To determine and evaluate the diagnostic performance of Doppler sonography of umbilical artery (UA), fetal middle cereberal artery (MCA), ductus venosus (VD) and umbilical vein (UV) for prediction of ...

Detailed Description

The included women age will range between 18 and 35 years old. They will be pregnant in a singleton healthy living fetus at a gestational age between 34 and 39 weeks (confirmed by a reliable date for ...

Eligibility Criteria

Inclusion

  • The included women age will range between 18 and 35 years old.
  • They will carry a singleton healthy living fetus at a gestational age between 34 and 39 weeks (confirmed by a reliable date for the last menstrual period or/and 1st trimester ultrasound scan).
  • known to be diabetic in the current pregnancy (PGDM or GDM).

Exclusion

  • Women with other maternal medical disorders that may affect perinatal outcome rather than diabetes were excluded from the study.
  • women with pre-labour rupture of membrane.
  • antepartum hemorrhage, fetuses with congenital anomalies .
  • who will receive respiratory depressants (e.g., opioid analgesics) within 2 hours of delivery.

Key Trial Info

Start Date :

June 15 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

October 20 2022

Estimated Enrollment :

140 Patients enrolled

Trial Details

Trial ID

NCT05410080

Start Date

June 15 2022

End Date

October 20 2022

Last Update

August 23 2022

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Cairo University

Cairo, Egypt, 02

2

Kasr Alainy hospital (Faculty of Medicine-Cairo University)

Cairo, Egypt, 11956